<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to evaluate fluorescence in situ hybridization abnormalities of the 2p23 anaplastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> kinase (ALK) gene loci in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with anaplastic <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 24 anaplastic large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>) classified by World Health Organization criteria [17 primary nodal/systemic (10 ALK+, 7 ALK-), seven primary cutaneous], and 17 additional non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> [one ALK+ B-lineage <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 14 ALK- diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (seven anaplastic variants, five nonanaplastic, two secondary CD30+), two follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>] </plain></SENT>
<SENT sid="2" pm="."><plain>ALK- <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with anaplastic <z:mp ids='MP_0000002'>morphology</z:mp> showed extra nonrearranged anaplastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> kinase gene loci (P=0.004) due to <z:mp ids='MP_0004027'>trisomy</z:mp> 2 irrespective of the following factors: B or T/null phenotype (P=0.315), diagnostic categories of systemic or cutaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> or the above-mentioned B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (P=0.131), and CD30 positivity by immunohistochemistry (P=1.000) </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 2 was absent in <z:hpo ids='HP_0000001'>all</z:hpo> ALK+ <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (P=0.009), which showed rearranged ALK gene loci (P&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Whether <z:mp ids='MP_0004027'>trisomy</z:mp> 2 is a primary or secondary event that leads to ALK- <z:hpo ids='HP_0002665'>lymphomas</z:hpo> cannot be determined from this study </plain></SENT>
<SENT sid="5" pm="."><plain>Its presence in secondary B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> suggests that <z:mp ids='MP_0004027'>trisomy</z:mp> 2 may be a secondary cytogenetic aberration in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in general </plain></SENT>
<SENT sid="6" pm="."><plain>Further investigation of this finding is necessary to further our understanding of the <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of ALK- <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>